1.
CANNT J
; 13(3): 66-8, 2003.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14596200
RESUMO
With the decrease in donor quality and the increase in recipient co-morbidities, transplantation immunosuppression is changing. New paradigms in transplantation include co-stimulation, lymphocyte retrafficking, and inhibiting antibody production. With these new paradigms come new immunosuppressive agents. While these new agents show great promise, their use in day-to-day clinical transplantation remains to be seen.